FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804591322> ?p ?o ?g. }

• W2804591322 endingPage "83" @default.
• W2804591322 startingPage "75" @default.
• W2804591322 abstract "Objective Lipid management is one of the cornerstones of cardiovascular risk reduction. Treatment of HIV infection with protease inhibitors (PIs) may cause dyslipidaemia, whilst the integrase inhibitor raltegravir (RAL) has a relatively favorable effect on plasma lipids. We examined the effect of switching from PIs to RAL on endothelial function, and its effect on immunological and inflammatory parameters. Methods We performed a 16-week open-label prospective crossover study: 8 weeks intervention (switch PIs to RAL) and 8 weeks control (unchanged cART regimen). Flow-mediated dilatation (FMD), inflammatory plasma, and cellular markers of immune activation were measured at weeks 0, 8, and 16. Results Study participants (n = 22) with a median age of 50 years (IQR 42-60) and known HIV infection of 6.5 years (IQR 5.0-17.3) were on stable cART with undetectable HIV viral loads. After 8 weeks of RAL therapy, a reduction in FMD of -0.81% was seen, compared to +0.54% control (pairwise, p = 0.051), while fasting total cholesterol (-17% versus +10%; p < 0.001), LDL cholesterol (-21% versus -3%; p = 0.026), and triglycerides (-41% versus +18%; p = 0.001) significantly decreased during RAL therapy compared to the control. Furthermore, a relation between the change in percentage of B-1 cells and the change in FMD was found (β 0.40, 95%CI 0.16; 0.64, p = 0.005) during treatment with RAL. Finally, during RAL therapy, 27% of the patients experienced an increased ALT rise. Conclusions We present an overall negative study, where switching from PIs to RAL slightly reduced the endothelial function while decreasing plasma lipids, thus possibly decreasing the CVD risk in the long term. A transient elevation of ALT was seen upon switch to RAL." @default.
• W2804591322 created "2018-06-01" @default.
• W2804591322 creator A5017091744 @default.
• W2804591322 creator A5034085466 @default.
• W2804591322 creator A5048394409 @default.
• W2804591322 creator A5049826686 @default.
• W2804591322 creator A5051969821 @default.
• W2804591322 creator A5061219669 @default.
• W2804591322 creator A5062869503 @default.
• W2804591322 creator A5073320977 @default.
• W2804591322 creator A5090784383 @default.
• W2804591322 date "2018-03-04" @default.
• W2804591322 modified "2023-10-16" @default.
• W2804591322 title "The effect of switching protease inhibitors to raltegravir on endothelial function, in HIV-infected patients" @default.
• W2804591322 cites W1677033108 @default.
• W2804591322 cites W1767400858 @default.
• W2804591322 cites W1966594448 @default.
• W2804591322 cites W1987915813 @default.
• W2804591322 cites W2001231188 @default.
• W2804591322 cites W2037870445 @default.
• W2804591322 cites W2050663836 @default.
• W2804591322 cites W2053071621 @default.
• W2804591322 cites W2054008010 @default.
• W2804591322 cites W2063506869 @default.
• W2804591322 cites W2078529164 @default.
• W2804591322 cites W2091797632 @default.
• W2804591322 cites W2095065201 @default.
• W2804591322 cites W2105343975 @default.
• W2804591322 cites W2106545917 @default.
• W2804591322 cites W2109712320 @default.
• W2804591322 cites W2123055341 @default.
• W2804591322 cites W2130312329 @default.
• W2804591322 cites W2133175709 @default.
• W2804591322 cites W2148835789 @default.
• W2804591322 cites W2150743195 @default.
• W2804591322 cites W2152789823 @default.
• W2804591322 cites W2157969042 @default.
• W2804591322 cites W2166535756 @default.
• W2804591322 cites W2167576798 @default.
• W2804591322 cites W2169264636 @default.
• W2804591322 cites W2200285648 @default.
• W2804591322 cites W2415979752 @default.
• W2804591322 cites W2443582141 @default.
• W2804591322 cites W2527768444 @default.
• W2804591322 cites W4256291905 @default.
• W2804591322 cites W4361972733 @default.
• W2804591322 doi "https://doi.org/10.1080/15284336.2018.1455366" @default.
• W2804591322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29770748" @default.
• W2804591322 hasPublicationYear "2018" @default.
• W2804591322 type Work @default.
• W2804591322 sameAs 2804591322 @default.
• W2804591322 citedByCount "5" @default.
• W2804591322 countsByYear W28045913222018 @default.
• W2804591322 countsByYear W28045913222019 @default.
• W2804591322 countsByYear W28045913222021 @default.
• W2804591322 countsByYear W28045913222022 @default.
• W2804591322 crossrefType "journal-article" @default.
• W2804591322 hasAuthorship W2804591322A5017091744 @default.
• W2804591322 hasAuthorship W2804591322A5034085466 @default.
• W2804591322 hasAuthorship W2804591322A5048394409 @default.
• W2804591322 hasAuthorship W2804591322A5049826686 @default.
• W2804591322 hasAuthorship W2804591322A5051969821 @default.
• W2804591322 hasAuthorship W2804591322A5061219669 @default.
• W2804591322 hasAuthorship W2804591322A5062869503 @default.
• W2804591322 hasAuthorship W2804591322A5073320977 @default.
• W2804591322 hasAuthorship W2804591322A5090784383 @default.
• W2804591322 hasBestOaLocation W28045913221 @default.
• W2804591322 hasConcept C126322002 @default.
• W2804591322 hasConcept C127413603 @default.
• W2804591322 hasConcept C142462285 @default.
• W2804591322 hasConcept C14430832 @default.
• W2804591322 hasConcept C181199279 @default.
• W2804591322 hasConcept C185592680 @default.
• W2804591322 hasConcept C188816634 @default.
• W2804591322 hasConcept C203014093 @default.
• W2804591322 hasConcept C2776714187 @default.
• W2804591322 hasConcept C2777275308 @default.
• W2804591322 hasConcept C2777302000 @default.
• W2804591322 hasConcept C2778163477 @default.
• W2804591322 hasConcept C2778270857 @default.
• W2804591322 hasConcept C2780404665 @default.
• W2804591322 hasConcept C2781413609 @default.
• W2804591322 hasConcept C2993143319 @default.
• W2804591322 hasConcept C3013748606 @default.
• W2804591322 hasConcept C55493867 @default.
• W2804591322 hasConcept C71924100 @default.
• W2804591322 hasConcept C78519656 @default.
• W2804591322 hasConcept C8891405 @default.
• W2804591322 hasConcept C90924648 @default.
• W2804591322 hasConceptScore W2804591322C126322002 @default.
• W2804591322 hasConceptScore W2804591322C127413603 @default.
• W2804591322 hasConceptScore W2804591322C142462285 @default.
• W2804591322 hasConceptScore W2804591322C14430832 @default.
• W2804591322 hasConceptScore W2804591322C181199279 @default.
• W2804591322 hasConceptScore W2804591322C185592680 @default.
• W2804591322 hasConceptScore W2804591322C188816634 @default.
• W2804591322 hasConceptScore W2804591322C203014093 @default.
• W2804591322 hasConceptScore W2804591322C2776714187 @default.

• next